FINRA to Spar for Consumer Rights on Wednesday

September 05, 2013

Yesterday, the New York Times published an interesting article regarding discount brokerage firm Charles Schwab & Company’s attempt to lessen (if not effectively eliminate) its exposure to liability for widespread investment related abuses. More specifically, in 2011, Schwab added a[...]

A Hero

August 27, 2013

I just finished a book about our profession at its very best. The book is Devil in the Grove, by Gilbert King.  A 2013 Pulitzer Prize winner for Non-Fiction, Devil in the Grove tells the story of a criminal trial[...]

Supreme Court Makes Second Landmark Ruling on the Liability of Generic Drug Manufacturers

August 19, 2013

Over the last year, I have written about the evolving law on an issue at the center of much controversy: the ability to bring product liability lawsuits against generic drug manufacturers.  While the Supreme Court determined that state law failure[...]

Wexler Wallace Walks with Lambda Legal

July 03, 2013

The 44th Annual Chicago Pride Parade was held Sunday on the north side of the city to record attendance. In the estimated crowd of 1 million, four Wexler Wallace employees marched along the parade route. Associates Amy Keller and Amber[...]

Utter Lunacy: Supreme Court strips individuals of their right to vindicate their claims in court, and Congress is in no hurry to un-do the damage

June 25, 2013

Building upon the absurd precedent created in AT&T Mobility v. Concepcion, this past Thursday, the Supreme Court issued an opinion which held that mandatory, binding arbitration clauses and class action waivers are enforceable, even if the cost of arbitrating an[...]

Supreme Court Makes Landmark Antitrust Ruling

June 18, 2013

The United States Supreme Court yesterday made a landmark antitrust decision that should hopefully have the effect of increasing generic competition with brand name drugs, lowering pharmaceutical costs for consumers and their insurers.  In Federal Trade Commission v. Actavis, Inc.,[...]